Priscilla Merriam

8PUBLICATIONS
79CO-AUTHORS
Molecular targetsAnimal systematics and taxonomyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 06, 2026
Patterns of Response to Immune Checkpoint Inhibitors in Sarcomas With High Tumor Burden and/or Mismatch Repair Deficiency.

|May 26, 2026
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.

|Apr 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|May 09, 2024
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma.

Gregory M Cote, Candace L Haddox, Edwin Choy

|Jan 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.

Candace L Haddox, Michael J Nathenson, Emanuele Mazzola

Pageof 2

Frequent Collaborators

6 joint publications

Suzanne George

4 joint publications

Edwin Choy

3 joint publications

Gregory M Cote

3 joint publications

Candace L Haddox